Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Partners With Stratos and Micronics to Commercialize Optical Mapping System

NEW YORK, April 5 (GenomeWeb News) - OpGen Technologies has partnered with Stratos Product Development and Micronics to develop and commercialize its first product, called the Optical Mapping System, the trio said today.


OpGen's Optical Mapping detects genome rearrangements, including insertions/deletions, translocations, inversions, repeats and gene amplification, the companies said. OpGen has partnered with the two Pacific Northwest life science firms to develop the commercial version of its system that can be used in-house. OpGen currently offers access to its technology as a service.


Under the terms of the agreement, Stratos will bring to the table its know-how in technology commercialization, systems integration, instrumentation development, and regulatory compliance, while Micronics will develop the disposable device on which the fluidics assay of the Optical Mapping technology is performed.


OpGen said in a statement earlier this week that it is aiming to launch the system in 2007.


Financial details were not disclosed.